Studies have demonstrated that the C10orf90 protein can inhibit the degradation rate of p53 and p21 proteins, thereby contributing to the occurrence and development of cancers, including non-small cell lung cancer, breast cancer, conjunctival melanoma, and pterygium and pinguecula. Here, TP53 is linked to non-small cell lung carcinoma.